{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:34:59Z","timestamp":1781530499475,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T00:00:00Z","timestamp":1468540800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AbbVie SrL, Italy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10072-016-2664-0","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T11:27:50Z","timestamp":1468582070000},"page":"1785-1792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Motor outcomes in patients with advanced Parkinson\u2019s disease treated with levodopa\/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study"],"prefix":"10.1007","volume":"37","author":[{"given":"Leonardo","family":"Lopiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Modugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Sensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Meco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Cannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Gusmaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Tamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Quatrale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Gualberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Melzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"di Luzio Paparatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,15]]},"reference":[{"issue":"2","key":"2664_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/erp.11.106","volume":"12","author":"P Martinez-Martin","year":"2012","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ (2012) Quality of life and burden in caregivers for patients with Parkinson\u2019s disease: concepts, assessment and related factors. Expert Rev Pharmacoecon Outcomes Res 12(2):221\u2013230","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"2664_CR2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5(3):235\u2013245","journal-title":"Lancet Neurol"},{"key":"2664_CR3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1176\/appi.neuropsych.11100315","volume":"24","author":"B Ozdilek","year":"2012","unstructured":"Ozdilek B, Gunal DI (2012) Motor and non-motor symptoms in Turkish patients with Parkinson\u2019s disease affecting family caregiver burden and quality of life. J Neuropsych Clin Neurosc 24:478\u2013483","journal-title":"J Neuropsych Clin Neurosc"},{"key":"2664_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.parkreldis.2005.06.011","volume":"12","author":"A Schrag","year":"2006","unstructured":"Schrag A, Hovris A, Moreley D, Quinn N, Jahanshahi M (2006) Caregiver-burden in parkinson\u2019s disease is closely associated with psychiatric symptoms, falls, and disability. Park Rel Disord 12:35\u201341","journal-title":"Park Rel Disord"},{"key":"2664_CR5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.21475","volume":"22","author":"G Fabbrini","year":"2007","unstructured":"Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG (2007) Levodopa induced dyskinesias. Mov Disord 22:1379\u20131389","journal-title":"Mov Disord"},{"key":"2664_CR6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00002826-200203000-00006","volume":"25","author":"D Nyholm","year":"2002","unstructured":"Nyholm D, Lennernas H, Gomes-Trolin C, Aquilonius SM (2002) Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson\u2019s disease on individual drugs combinations. Clin Neuropharmacol 25:89\u201396","journal-title":"Clin Neuropharmacol"},{"key":"2664_CR7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1208\/s12248-012-9439-1","volume":"15","author":"D Nyholm","year":"2013","unstructured":"Nyholm D, Odin P, Johansson A, Chatamra K, Locke C, Dutta S, Othman AA (2013) Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-h jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease patients. AAPS J 15:316\u2013323","journal-title":"AAPS J"},{"issue":"3","key":"2664_CR8","first-page":"147","volume":"27","author":"G Abbruzzese","year":"2012","unstructured":"Abbruzzese G, Barone P, Bonuccelli U, Lopiano L, Antonini A (2012) Continuous intestinal infusion of levodopa\/carbidopa in advanced Parkinson\u2019s disease: efficacy, safety and patient selection. Funct Neurol 27(3):147\u2013154","journal-title":"Funct Neurol"},{"key":"2664_CR9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-013-1026-9","volume":"120","author":"A Antonini","year":"2013","unstructured":"Antonini A, Odin P, Lopiano L, Tomantschger V, Pacchetti C, Pickut B, Gasser UE, Calandrella D, Mancini F, Zibetti M, Minafra B, Bertaina I, De Deyn P, Cras C, Wolf E, Spielberger S, Poewe W (2013) Effect and safety of duodenal levodopa infusion in advanced Parkinson\u2019s disease: a retrospective multicenter outcome assessment in patient routine care. J Neural Transm 120:1553\u20131558","journal-title":"J Neural Transm"},{"key":"2664_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26528","author":"A Antonini","year":"2016","unstructured":"Antonini A, Fung VSC, Boyd JT, Slevin JT, Hall C, Chatamra K, Eaton S, Benesh JA (2016) Effect of levodopa\u2013carbidopa intestinal gel on dyskinesia in advanced Parkinson\u2019s Disease patients. Mov Disord. doi: 10.1002\/mds.26528","journal-title":"Mov Disord"},{"key":"2664_CR11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/wnf.0b013e31814b113e","volume":"31","author":"K Eggert","year":"2008","unstructured":"Eggert K, Schrader C, Hahn M, Stamelou M, Russmann A, Dengler R, Oertel W, Odin P (2008) Continuous jejunal levodopa infusion in patients with advanced Parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol 31:151\u2013166","journal-title":"Clin Neuropharmacol"},{"issue":"10","key":"2664_CR12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/mds.22596","volume":"24","author":"H Honig","year":"2009","unstructured":"Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chauduri KR (2009) Intrajejunal levodopa infusion in Parkinson\u2019s disease. A pilot multicenter study of effects on non motor symptoms and quality of life. Mov Disord 24(10):1468\u20131474","journal-title":"Mov Disord"},{"issue":"5","key":"2664_CR13","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/ane.12075","volume":"127","author":"M Zibetti","year":"2013","unstructured":"Zibetti M, Rizzone M, Merola A, Angrisano S, Rizzi L, Montanaro E, Cicolin A, Lopiano L (2013) Sleep improvement with levodopa\/carbidopa intestinal gel infusion in Parkinson disease. Acta Neurol Scand 127(5):e28\u2013e32","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2664_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00415-012-6597-0","volume":"260","author":"M Zibetti","year":"2013","unstructured":"Zibetti M, Merola A, Ricchi V, Marchisio A, Artusi CA, Rizzi L, Montanaro E, Reggio D, De Angelis C, Rizzone M, Lopiano L (2013) Long-term duodenal levodopa infusion in Parkinson\u2019s disease: a 3-year motor and cognitive follow-up study. J Neurol 260(1):105\u2013114","journal-title":"J Neurol"},{"issue":"2","key":"2664_CR15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/ene.12309","volume":"21","author":"M Zibetti","year":"2014","unstructured":"Zibetti M, Merola A, Artusi CA, Rizzi L, Angrisano S, Reggio D, De Angelis C, Rizzone M, Lopiano L (2014) Levodopa\/carbidopa intestinal gel infusion in advanced Parkinson\u2019s disease: a 7-year experience. Eur J Neurol 21(2):312\u2013318","journal-title":"Eur J Neurol"},{"issue":"6","key":"2664_CR16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00702-013-1153-3","volume":"121","author":"M Sensi","year":"2014","unstructured":"Sensi M, Preda F, Trevisani L, Contini E, Gragnaniello D, Capone JG, Sette E, Golfre-Andreasi N, Tugnoli V, Tola MR, Quatrale R (2014) Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients. J Neural Transm 121(6):633\u2013642","journal-title":"J Neural Transm"},{"key":"2664_CR17","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1212\/WNL.0000000000001500","volume":"84","author":"D Calandrella","year":"2015","unstructured":"Calandrella D, Romito LM, Elia AE, Del Sorbo F, Bagella CF, Falsitta M, Albanese A (2015) Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease. Neurology 84:1669\u20131672","journal-title":"Neurology"},{"issue":"5","key":"2664_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/WNF.0b013e3182613dea","volume":"35","author":"P Reddy","year":"2012","unstructured":"Reddy P, Martinez-Martin P, Rizos A, Martin A, Faye GC, Forgacs I, Odin P, Antonini A, Chaudhuri KR (2012) Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects. Clin Neuropharmacol 35(5):205\u2013217","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"2664_CR19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.26123","volume":"30","author":"HH Fernandez","year":"2015","unstructured":"Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, Robieson WZ, Benesh JA, Espay AJ (2015) Levodopa\u2013carbidopa intestinal gel in advanced Parkinson\u2019s disease: final 12-month, open-label results. Mov Disord 30(4):500\u2013509","journal-title":"Mov Disord"},{"issue":"1","key":"2664_CR20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/JPD-140456","volume":"5","author":"JT Slevin","year":"2015","unstructured":"Slevin JT, Fernandez HH, Zadikoff C, Hall C, Eaton S, Dubow J, Chatamra K, Benesh J (2015) Long-term safety and maintenance of efficacy of Levodopa\u2013Carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson\u2019s disease patients. J Parkinsons Dis 5(1):165\u2013174","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"2664_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.parkreldis.2014.12.012","volume":"21","author":"A Antonini","year":"2015","unstructured":"Antonini A, Yegin A, Preda C, Bergmann L, Poewe W, On behalf of the GLORIA study investigators and coordinators (2015) Global long-term study on motor and non-motor symptoms and safety of levodopa\u2013carbidopa intestinal gel in routine care of advanced Parkinson\u2019s disease patients; 12-month interim outcomes. Parkinsonism Relat Disord 21(3):231\u2013235","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2664_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","volume":"13","author":"CW Olanow","year":"2014","unstructured":"Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A, For the LCIG Horizon Study Group (2014) Continuous intrajejunal infusion of levodopa\u2013carbidopa intestinal gel for patients with advanced Parkinson\u2019s disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 13(2):141\u2013149","journal-title":"Lancet Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-016-2664-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-016-2664-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-016-2664-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T01:05:41Z","timestamp":1600909541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-016-2664-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["2664"],"URL":"https:\/\/doi.org\/10.1007\/s10072-016-2664-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,15]]}}}